SOURCE: Horizon Pharma plc

Horizon Pharma plc

April 09, 2015 07:00 ET

Horizon Pharma plc Names Geoffrey M. Curtis Group Vice President, Corporate Communications

DUBLIN, IRELAND--(Marketwired - Apr 9, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today named Geoffrey M. Curtis group vice president, corporate communications, reporting directly to Timothy P. Walbert, chairman, president and chief executive officer, effective immediately. Curtis will oversee corporate and product communications, media relations and internal communications activities.

"Geoff and I have worked closely for over ten years and it is a pleasure to have him join Horizon to build out our communications function," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. "Geoff's experience in working and launching multiple brands across various market and therapeutic segments will be valuable as we accelerate our product and corporate communication activities."

Curtis brings nearly two decades of global healthcare communications experience including media relations, corporate and product communications and executive visibility. Most recently, Geoff was a senior vice president at Edelman Public Relations and as part of its National Health Media Team, he led media strategy and execution for a large portfolio of pharmaceutical, biotech and medical device clients. He was responsible for developing and maintaining media relationships, as well as implementing media strategies to support regulatory and product milestones, data publication and global medical meetings.

"I'm excited about joining Horizon Pharma during a time of significant growth and look forward to working with the executive team to build and shape the corporate communications function," said Curtis.

Previously, Curtis was group director of the media practice at WCG, a W20 Group company, where he provided product and corporate communications counsel and handled ongoing media relations for a broad range of healthcare clients. Before WCG, Geoff held a similar role at GCI Group.

Prior to joining GCI, Curtis served as a public affairs manager in the Pharmaceutical Products Division at Abbott (now AbbVie), where he led internal and external communications programs for the immunology, neuroscience and oncology franchises.

Geoff is a graduate of the Lake Forest College in Lake Forest, Illinois where he received his bachelor's degree in English.

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases. The company's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

Contact Information